The treatment of IBD-associated arthritis consists of nonsteroidal anti-inflammatory drugs (NSAIDs), local glucocorticoid injection, sulfasalazine, methotrexate (MTX), biologics such as tumor necrosis factor inhibitors, and ustekinumab blocking interleukins 12 and 23. The gene discussed is TNF; the disease is arthritic joint disease.